169 related articles for article (PubMed ID: 11153754)
1. Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy.
Sakata Y; Masuyama T; Yamamoto K; Doi R; Mano T; Kuzuya T; Miwa T; Takeda H; Hori M
J Am Coll Cardiol; 2001 Jan; 37(1):293-9. PubMed ID: 11153754
[TBL] [Abstract][Full Text] [Related]
2. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
[TBL] [Abstract][Full Text] [Related]
3. Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart.
Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Hori M
J Hypertens; 2002 Apr; 20(4):753-61. PubMed ID: 11910313
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.
Sakata Y; Masuyama T; Yamamoto K; Nishikawa N; Yamamoto H; Kondo H; Ono K; Otsu K; Kuzuya T; Miwa T; Takeda H; Miyamoto E; Hori M
Circulation; 2000 Oct; 102(18):2269-75. PubMed ID: 11056104
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin-angiotensin system in hypertensive rats.
Fukui S; Fukumoto Y; Suzuki J; Saji K; Nawata J; Shinozaki T; Kagaya Y; Watanabe J; Shimokawa H
Hypertens Res; 2009 Jun; 32(6):472-80. PubMed ID: 19390543
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study.
Basset A; Blanc J; Messas E; Hagège A; Elghozi JL
J Cardiovasc Pharmacol; 2001 Feb; 37(2):163-72. PubMed ID: 11209999
[TBL] [Abstract][Full Text] [Related]
7. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Yoshida J; Miwa T; Sugawara M; Yamaguchi Y; Ookawara T; Suzuki K; Hori M
Cardiovasc Res; 2002 Jul; 55(1):76-82. PubMed ID: 12062710
[TBL] [Abstract][Full Text] [Related]
8. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease.
Ishizu T; Seo Y; Kameda Y; Kawamura R; Kimura T; Shimojo N; Xu D; Murakoshi N; Aonuma K
Hypertension; 2014 Mar; 63(3):500-6. PubMed ID: 24396022
[TBL] [Abstract][Full Text] [Related]
10. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
[TBL] [Abstract][Full Text] [Related]
11. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction.
Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Miwa T; Hori M; Masuyama T
Cardiovasc Res; 2003 Mar; 57(3):757-65. PubMed ID: 12618237
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic, morphometric and autonomic patterns in hypertensive rats - Renin-Angiotensin system modulation.
Zamo FS; Lacchini S; Mostarda C; Chiavegatto S; Silva IC; Oliveira EM; Irigoyen MC
Clinics (Sao Paulo); 2010; 65(1):85-92. PubMed ID: 20126350
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of cardiotrophin-1-expressing myoblasts to the left ventricular wall alleviates the transition from compensatory hypertrophy to congestive heart failure in Dahl salt-sensitive hypertensive rats.
Toh R; Kawashima S; Kawai M; Sakoda T; Ueyama T; Satomi-Kobayashi S; Hirayama S; Yokoyama M
J Am Coll Cardiol; 2004 Jun; 43(12):2337-47. PubMed ID: 15193703
[TBL] [Abstract][Full Text] [Related]
14. Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.
Yamamoto M; Ishizu T; Seo Y; Suto Y; Sai S; Xu D; Murakoshi N; Kimura T; Kawakami Y; Aonuma K
J Card Fail; 2018 Jan; 24(1):53-60. PubMed ID: 28888840
[TBL] [Abstract][Full Text] [Related]
15. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
17. Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats.
Kobayashi N; Nishikimi T; Horinaka S; Ishimitsu T; Matsuoka H
Atherosclerosis; 2001 Jun; 156(2):255-65. PubMed ID: 11395021
[TBL] [Abstract][Full Text] [Related]
18. Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure.
Sakata Y; Yamamoto K; Masuyama T; Mano T; Nishikawa N; Kuzuya T; Miwa T; Hori M
J Hypertens; 2001 Oct; 19(10):1905-12. PubMed ID: 11593113
[TBL] [Abstract][Full Text] [Related]
19. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
Nakajima Y; Ito S; Asakura M; Min KD; Fu HY; Imazu M; Hitsumoto T; Takahama H; Shindo K; Fukuda H; Yamazaki S; Asanuma H; Kitakaze M
J Mol Cell Cardiol; 2019 Apr; 129():257-265. PubMed ID: 30880253
[TBL] [Abstract][Full Text] [Related]
20. Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats.
Kobayashi N; Higashi T; Hara K; Shirataki H; Matsuoka H
Cardiovasc Res; 1999 Dec; 44(3):518-26. PubMed ID: 10690283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
